Receptor Imaging in Oncology by Means of Nuclear Medicine: Current Status

2004 ◽  
Vol 22 (17) ◽  
pp. 3593-3607 ◽  
Author(s):  
Bieke Van Den Bossche ◽  
Christophe Van de Wiele
Keyword(s):  
Computed Tomography ◽  
Receptor Expression ◽  
Whole Body ◽  
Current Status ◽  
Emission Computed Tomography ◽  
Receptor Imaging ◽  
Whole Body Imaging ◽  
In Vivo Distribution ◽  
Tissue Manipulation

To date, our understanding of the role of receptors and their cognate ligands in cancer is being successfully translated into the design and development of an arsenal of new, less toxic, and more specific anticancer drugs. Because most of these novel drugs are cytostatic, objective response as measured by morphologic imaging modalities (eg, computed tomography or magnetic resonance imaging) cannot be used as a surrogate marker for drug development or for clinical decision making. Positron emission tomography (PET) can be used to image and quantify the in vivo distribution of positron-emitting radioisotopes such as oxygen-15, carbon-11, and fluorine-18 that can be substituted or added into biologically relevant and specific receptor radioligands. Similarly, single-photon emission computed tomography (SPECT) can be used to image and quantify the in vivo distribution of receptor targeting compounds labeled with indium-111, technetium-99m, and iodine-123. By virtue of their whole-body imaging capacity and the absence of errors of sampling and tissue manipulation as well as preparation, both techniques have the potential to address locoregional receptor status noninvasively and repetitively. This article reviews available data on the in vivo evaluation of receptor systems by means of PET or SPECT for identifying and monitoring patients with sufficient receptor overexpression for tailored therapeutic interventions, and also for depicting tumor tissue and determining the currently largely unknown heterogeneity in receptor expression among different tumor lesions within and between patients.

scholarly journals Nuclear Medicine Imaging in Neuroblastoma: Current Status and New Developments

2021 ◽  
Vol 11 (4) ◽  
pp. 270
Author(s):  
Atia Samim ◽  
Godelieve A.M. Tytgat ◽  
Gitta Bleeker ◽  
Sylvia T.M. Wenker ◽  
Kristell L.S. Chatalic ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Nuclear Medicine ◽  
Single Photon ◽  
Photon Emission ◽  
Treatment Strategies ◽  
Whole Body ◽  
Current Status ◽  
Emission Computed Tomography ◽  
Nuclear Medicine Imaging ◽  
Disease Extent

Neuroblastoma is the most common extracranial solid malignancy in children. At diagnosis, approximately 50% of patients present with metastatic disease. These patients are at high risk for refractory or recurrent disease, which conveys a very poor prognosis. During the past decades, nuclear medicine has been essential for the staging and response assessment of neuroblastoma. Currently, the standard nuclear imaging technique is meta-[123I]iodobenzylguanidine ([123I]mIBG) whole-body scintigraphy, usually combined with single-photon emission computed tomography with computed tomography (SPECT-CT). Nevertheless, 10% of neuroblastomas are mIBG non-avid and [123I]mIBG imaging has relatively low spatial resolution, resulting in limited sensitivity for smaller lesions. More accurate methods to assess full disease extent are needed in order to optimize treatment strategies. Advances in nuclear medicine have led to the introduction of radiotracers compatible for positron emission tomography (PET) imaging in neuroblastoma, such as [124I]mIBG, [18F]mFBG, [18F]FDG, [68Ga]Ga-DOTA peptides, [18F]F-DOPA, and [11C]mHED. PET has multiple advantages over SPECT, including a superior resolution and whole-body tomographic range. This article reviews the use, characteristics, diagnostic accuracy, advantages, and limitations of current and new tracers for nuclear medicine imaging in neuroblastoma.

scholarly journals Radionuclide, magnetic resonance and computed tomography imaging in European round back slugs (Arionidae) and leopard slugs (Limacidae)

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Nicola Beindorff ◽  
Fabian Schmitz-Peiffer ◽  
Daniel Messroghli ◽  
Winfried Brenner ◽  
Janet F. Eary
Keyword(s):  
Computed Tomography ◽  
Magnetic Resonance ◽  
Kidney Function ◽  
Single Photon ◽  
Photon Emission ◽  
Functional Anatomy ◽  
Whole Body ◽  
Emission Computed Tomography ◽  
Whole Body Imaging ◽  
Imaging Protocol

AbstractOther than in animal models of human disease, little functional imaging has been performed in most of the animal world. The aim of this study was to explore the functional anatomy of the European round back slug (Arionidae) and leopard slug (Limacidae) and to establish an imaging protocol for comparative species study. Radionuclide images with single photon emission computed tomography (SPECT) and positron emission tomography (PET) were obtained after injections of standard clinical radiopharmaceuticals 99mtechnetium dicarboxypropane diphosphonate (bone scintigraphy), 99mtechnetium mercaptoacetyltriglycine (kidney function), 99mtechnetium diethylenetriaminepentaacetic acid (kidney function), 99mtechnetium pertechnetate (mediated by the sodium-iodide symporter), 99mtechnetium sestamibi (cardiac scintigraphy) or 18F-fluoro-deoxyglucose (glucose metabolism) in combination with magnetic resonance imaging (MRI) and computed tomography (CT) for uptake anatomic definition. Images were compared with anatomic drawings for the Arionidae species. Additionally, organ uptake data was determined for a description of slug functional anatomy in comparison to human tracer biodistribution patterns identifying the heart, the open circulatory anatomy, calcified shell remnant, renal structure (nephridium), liver (digestive gland) and intestine. The results show the detailed functional anatomy of Arionidae and Limacidae, and describe an in vivo whole-body imaging procedure for invertebrate species.

scholarly journals Functional visualization in diseases of the joints: current status and prospects (clinical lecture)

2021 ◽  
Vol 29 (3) ◽  
pp. 125-142
Author(s):  
M.V. Satyr ◽  
О.І. Solodiannykova ◽  
I.V. Noverko ◽  
О.Yu. Galchenko
Keyword(s):  
Computed Tomography ◽  
Nuclear Medicine ◽  
Musculoskeletal System ◽  
Whole Body ◽  
Current Status ◽  
Differential Diagnostics ◽  
Emission Computed Tomography ◽  
Pathological Changes ◽  
High Priority Task ◽  
The World

Background. Diseases of the musculoskeletal system (MSS), in particular diseases of joints, are a leading factor for reducing the work ability of the population all around the world. The early diagnosis and treatment for them is a high priority task for clinical medicine. Modern nuclear medicine methods can significantly increase the possibilities in differential diagnostics, optimize treatment and improve the prognosis of diseases of the musculoskeletal system (MOP). Purpose – to study and generalize the world experience of application of modern methods of osteoscintigraphy (OSG) for diagnostics of joints diseases, to define possibilities and prospects of various scintigraphic acquisitions for investigation patients with MSS pathology. Materials and methods. Full-text publications in the databases Scopus, Web of Science Core Collection, PubMed (mostly 2015–2021), international standard guidelines for the diagnosis of MSS pathology and monographs for radionuclide examination methods and hybrid imaging technologies in oncology, orthopedics and traumatology. Results. We received the main approaches for radiological diagnostics of pathological changes in joints and the abilities of osteoscintigraphy. We defined the main principles and analyzed the possibilities and advantages of different nuclear medicine protocols: conventional planar examination of the whole body, 3-phase OSG, single-photon emission computed tomography (SPECT) and combined technology with X-ray computed tomography (SPECT/CT). Indications for the use of OSG in various pathological changes of ORA have been determined. We considered different patterns of radiation imaging according to the pathogenesis of various pathological processes – systemic arthritis, diseases of the joints of the spine, upper and lower extremities. The possibilities of different radiological methods for diagnosing and application of different modes of OSG depending on the pathogenesis and localization of lesions were analyzed and compared. Conclusions. Performing 3-phase OSG and tomographic modes (SPECT, SPECT/CT) significantly increases the efficiency of the method for the diagnostics, determination of process activity, staging and prevalence of joint pathology, as well as for monitoring the treatment results. The method detects active metabolic processes at an early stage in the vascular, soft tissue and bone phases and determines the condition of the joints of the whole body without additional radiation exposure.

scholarly journals Imaging of Folate Receptor Expressing Macrophages in the Rat Groove Model of Osteoarthritis: Using a New DOTA-Folate Conjugate

Cartilage ◽  
2017 ◽  
Vol 9 (2) ◽  
pp. 183-191 ◽  
Author(s):  
Huub M. de Visser ◽  
Nicoline M. Korthagen ◽  
Cristina Müller ◽  
Ruud M. Ramakers ◽  
Gerard C. Krijger ◽  
...  
Keyword(s):  
Computed Tomography ◽  
High Fat Diet ◽  
Folate Receptor ◽  
Cartilage Damage ◽  
Receptor Expression ◽  
Emission Computed Tomography ◽  
Albumin Binding ◽  
High Fat ◽  
Folate Conjugate

Objective To evaluate the presence and localization of folate receptor expressing macrophages in the rat groove model of osteoarthritis and determine the suitability of a new folate conjugate with albumin-binding entity (cm09) for in vivo SPECT (single-photon emission computed tomography) analysis. Design In male Wistar rats, local cartilage damage was induced in addition to a standard ( n = 10) or high-fat diet ( n = 6). After 12 weeks, 111In labeled folate conjugates were administered, and SPECT/CT (computed tomography) imaging was performed after 24 hours. Subsequently, osteoarthritis severity and folate receptor expression were assessed using (immuno)-histological sections. Results In vivo SPECT/CT imaging of the new folate conjugate (cm09) was as useful as a folate conjugate without albumin-binding entity in the groove model of osteoarthritis with less renal accumulation. Induction of cartilage damage on a standard diet resulted in no effect on the amount of folate receptor expressing macrophages compared with the contralateral sham operated joints. In contrast, inducing cartilage damage in the high-fat diet group resulted in 28.4% increase of folate receptor expression as compared with the nondamaged control joints. Folate receptor expressing cells were predominantly present in the synovial lining and in subchondral bone as confirmed by immunohistochemistry. Conclusions Folate receptor expression, and thus macrophage activation, can clearly be demonstrated in vivo, in small animal models of osteoarthritis using the new 111In-folate conjugate with specific binding to the folate receptor. Increased macrophage activity only plays a role in the groove model of osteoarthritis when applied in a high-fat diet induced dysmetabolic condition, which is in line with the higher inflammatory state of that specific model.

scholarly journals An Appropriate Method of Measuring Bone Metastatic Subtypes by In Vivo Advanced Imaging from Clinical to Preclinical Study

2021 ◽  
Author(s):  
Limin Fan ◽  
Meiping Shi ◽  
Jie Cao ◽  
Hongchao Fu ◽  
Jianzhong Su ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Lung Cancer ◽  
Cancer Cells ◽  
Lung Cancer Cells ◽  
Human Lung Cancer ◽  
Whole Body ◽  
Bone Lesions ◽  
Emission Computed Tomography ◽  
Advanced Imaging

Abstract Purpose: Bone metastasis (BM) lesions are always considered to be non-measurable. In this study, we established a method that proved to be measurable the subtypes of BM by in vivo advanced imaging including bone scintigraphy (BS) and single-photon emission computed tomography (SPECT) with 99mTechnetium-methylene diphosphonate (99mTc-MDP) fused computed tomography (CT), combined with skeletal radiography (XR). Methods: One retrospective clinical audit was investigated on lung cancer patients who suffer from BM. The audit includes early static planar, later Whole-body skeleton images and a random sample of 198 patients who were performed on fusion of SPECT/CT scanners. Among them, 108 patients with BM were definite histologic diagnosed with lung cancer and 257 bone lesions were classified. A preclinical precision study developed a procedure of hot spot-based bone imaging screening experimental BM clone by performing anesthesia, intracardiac injection of five human lung cancer cells on the immunodeficient mice, reanimate, in vivo imaging and in vitro experiments (cell culture, histology, karyotype analysis, microarrays, real-time polymerase chain reaction assay (RT-PCR), and immunohistochemistry (IHC)). An osteolytic metastatic clone MDA-MB-231Bo (231Bo) was compared. Irradiation damage was tested. Results: The clinical reports showed the incidence was primarily osteoblastic lesions, followed by mixed lesions and osteolytic. This study does not only confirmed the in vivo advanced imaging could be used to monitor and measure the subtypes of BM from clinical and preclinical data but also have ideal images (including movies), unique cell lines same as homo-sapiens, two markers associated with BM, TMEM100 and CDH1, as well as data from five pairs (BM clones and their parental cells) of lung cancer cells that released into GEO for further research. Ionizing radiation is controlled at its best. Conclusion: The studies have demonstrated that bone lesions of 1mm or larger can be detected in mouse models. Osteolytic lesions were revealed that a flow of metastatic cells out of the destroying cortical bone gap to form a soft tissue tumor. This study and GEO data are applicable to the development of relevant research and treatments.

scholarly journals Multiple Myeloma: A Review of Imaging Features and Radiological Techniques

2011 ◽  
Vol 2011 ◽  
pp. 1-9 ◽  
Author(s):  
C. F. Healy ◽  
J. G. Murray ◽  
S. J. Eustace ◽  
J. Madewell ◽  
P. J. O'Gorman ◽  
...  
Keyword(s):  
Computed Tomography ◽  
Multiple Myeloma ◽  
Plasma Cells ◽  
Imaging Techniques ◽  
Staging System ◽  
Whole Body ◽  
Emission Computed Tomography ◽  
Whole Body Imaging ◽  
Imaging Features ◽  
Positron Emission

The recently updated Durie/Salmon PLUS staging system published in 2006 highlights the many advances that have been made in the imaging of multiple myeloma, a common malignancy of plasma cells. In this article, we shall focus primarily on the more sensitive and specific whole-body imaging techniques, including whole-body computed tomography, whole-body magnetic resonance imaging, and positron emission computed tomography. We shall also discuss new and emerging imaging techniques and future developments in the radiological assessment of multiple myeloma.

scholarly journals Current Status of Putative Animal Sources of SARS-CoV-2 Infection in Humans: Wildlife, Domestic Animals and Pets

2021 ◽  
Vol 9 (4) ◽  
pp. 868
Author(s):  
Max Maurin ◽  
Florence Fenollar ◽  
Oleg Mediannikov ◽  
Bernard Davoust ◽  
Christian Devaux ◽  
...  
Keyword(s):  
Animal Species ◽  
Biological Properties ◽  
Experimental Models ◽  
Current Data ◽  
The Body ◽  
Receptor Expression ◽  
Current Status ◽  
Susceptible Animal

SARS-CoV-2 is currently considered to have emerged from a bat coronavirus reservoir. However, the real natural cycle of this virus remains to be elucidated. Moreover, the COVID-19 pandemic has led to novel opportunities for SARS-CoV-2 transmission between humans and susceptible animal species. In silico and in vitro evaluation of the interactions between the SARS-CoV-2 spike protein and eucaryotic angiotensin-converting enzyme 2 (ACE2) receptor have tentatively predicted susceptibility to SARS-CoV-2 infection of several animal species. Although useful, these data do not always correlate with in vivo data obtained in experimental models or during natural infections. Other host biological properties may intervene such as the body temperature, level of receptor expression, co-receptor, restriction factors, and genetic background. The spread of SARS-CoV-2 also depends on the extent and duration of viral shedding in the infected host as well as population density and behaviour (group living and grooming). Overall, current data indicate that the most at-risk interactions between humans and animals for COVID-19 infection are those involving certain mustelids (such as minks and ferrets), rodents (such as hamsters), lagomorphs (especially rabbits), and felines (including cats). Therefore, special attention should be paid to the risk of SARS-CoV-2 infection associated with pets.

scholarly journals Whole-Body Imaging to Assess Cell-Based Immunotherapy: Preclinical Studies with an Update on Clinical Translation

2021 ◽  
Author(s):  
Noriko Sato ◽  
Peter L. Choyke
Keyword(s):  
T Cell ◽  
Cell Tracking ◽  
Checkpoint Inhibitors ◽  
Cell Receptor ◽  
Clinical Translation ◽  
Whole Body ◽  
Whole Body Imaging ◽  
Body Imaging ◽  
Cell Therapies

AbstractIn the past decades, immunotherapies against cancers made impressive progress. Immunotherapy includes a broad range of interventions that can be separated into two major groups: cell-based immunotherapies, such as adoptive T cell therapies and stem cell therapies, and immunomodulatory molecular therapies such as checkpoint inhibitors and cytokine therapies. Genetic engineering techniques that transduce T cells with a cancer-antigen-specific T cell receptor or chimeric antigen receptor have expanded to other cell types, and further modulation of the cells to enhance cancer targeting properties has been explored. Because cell-based immunotherapies rely on cells migrating to target organs or tissues, there is a growing interest in imaging technologies that non-invasively monitor transferred cells in vivo. Here, we review whole-body imaging methods to assess cell-based immunotherapy using a variety of examples. Following a review of preclinically used cell tracking technologies, we consider the status of their clinical translation.

scholarly journals Radioanalytical Techniques to Quantitatively Assess the Biological Uptake and In Vivo Behavior of Hazardous Substances

Molecules ◽  
2020 ◽  
Vol 25 (17) ◽  
pp. 3985
Author(s):  
Jae Young Lee ◽  
Sajid Mushtaq ◽  
Jung Eun Park ◽  
Hee Soon Shin ◽  
So-Young Lee ◽  
...  
Keyword(s):  
Nuclear Imaging ◽  
Hazardous Substances ◽  
Environmental Research ◽  
Whole Body ◽  
Whole Body Imaging ◽  
Toxic Substances ◽  
Industrial Chemicals ◽  
Biological Uptake ◽  
Radioanalytical Methods

Concern about environmental exposure to hazardous substances has grown over the past several decades, because these substances have adverse effects on human health. Methods used to monitor the biological uptake of hazardous substances and their spatiotemporal behavior in vivo must be accurate and reliable. Recent advances in radiolabeling chemistry and radioanalytical methodologies have facilitated the quantitative analysis of toxic substances, and whole-body imaging can be achieved using nuclear imaging instruments. Herein, we review recent literature on the radioanalytical methods used to study the biological distribution, changes in the uptake and accumulation of hazardous substances, including industrial chemicals, nanomaterials, and microorganisms. We begin with an overview of the radioisotopes used to prepare radiotracers for in vivo experiments. We then summarize the results of molecular imaging studies involving radiolabeled toxins and their quantitative assessment. We conclude the review with perspectives on the use of radioanalytical methods for future environmental research.

Sign in / Sign up

Export Citation Format

Share Document